2American Diabetes Association, American Academy of Neurology.Consensus statement. Report and recommendations of the San Anto-nio conference on diabetic neuropathy. Diabetes Care, 1988, 11:592.
3Ewing DJ, Clarke BF. Diagnosis and management of diabetic auto-nomic neuropathy. Br Med J,1982,285:916.
4Ewing DJ, Marrzn CN, Young RS,et al. The value of cardiovascu-lar autonomic function test: 10 years experience in diabetes. Dia-betes Care, 1985,8:491.
5Faerman I, Faccio E, Milei J, et al. Autonomic neuropathy andpainless myocardial infarction in diabetic patient: histological evi-dence of their relationship. Diabetes, 1977,26:1147.
6Ewing DJ, Campbell IW, Clarke BF. The natural history of diabeticautonomic neuropathy. Q J Med, 1980,49:95.
7Navarro X, Kennedy WR, Loewenson RB, et al. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes. Diabetes, 1990,39:802.
8Brien IAD, McFadden JP, Corral RJM. The influence of autonomicneuropathy on mortality in insulin-dependent diabetes. Q .J Med,1991, 79:495.
9Aytemir K,Aksozek S, Ozer N, et al. QT dispersion and autonomic nervous system function in patients with type 1 diabetes. Inter J Cardiol, 1998,65:45.
10Tsuji H, Larson MG, Venditti FJ, et al. Impact of reduced heartrate variability on risk for cardiac events. The Framingham HeartStudy. Circulation, 1996,94(11):2850.
3FAUCHIER L,BABUTY D,FAUCHIER J P.Heart rate variability and prognosis in coronary artery disease[J].Eur Heart J,1999,20:1135-1136.
4WEBER F,SCHNEIDER H,VON ARNIM T,et al.Heart rate variability and ischaemia in patients with coronary heart diease and stable angina pectoris:Influence of drug therapy and prognostic value[J].Eur Heart J,1999,20:38-50.
